Explore 3 Stock Ideas & Industry Insights Download Free Report

blue-chip

Book Profit in This NYSE-Listed Gold Stock – GOLD

Apr 13, 2022 | Team Kalkine
Book Profit in This NYSE-Listed Gold Stock – GOLD

 

Barrick Gold Corporation

Barrick Gold Corporation (NYSE: GOLD) is a Canadian gold mining company that focuses on the production and sale of gold and copper and other related activities such as exploration and mine development. Argentina, Australia, Canada, Chile, Dominican Republic, Papua New Guinea, Peru, Saudi Arabia, the United States, and Zambia all have mining operations.

Why Should Investors Book Profit?

  • Low ROE: GOLD reported ROE of 8.6% in FY21 compared to Industry Median of 9.1%.
  • High Cash Conversion Days: Compared to the industry, the company has a long Cash Conversion Cycle (Days), meaning that it takes more days to convert its sales to cash. As of FY21, its Cash Cycle was 81 days, compared to an industry median of 63 days.
  • Technical weakness: GOLD’s price moved up by 26.75% from the recommended entry price and made a high of USD 25.91 on April 11, 2022. Price reached a crucial resistance level of USD 25.91 but were unable to break this level, indicating the possibility of a downside correction which may lead the prices towards the resistance turned support level USD 23.60. On the daily chart, RSI (14-period) is reached an overbought zone at 70.91 levels, supporting a downside correction. However, prices are still sustaining above the trend-following indicators 21-period SMA and 50-period SMA and may act as the support levels for the stock.

Valuation Methodology: Price/Cash Flow Based Relative Valuation

(Analysis by Kalkine Group)

* % Premium/(Discount) is based on our assessment of the company's FY1 trading multiple after considering its key growth drivers, economic moat, stock's historical trading multiples versus peer average/median, and investment risks.

Stock Recommendation:

GOLD's share price has inclined 36.95% in the past six months and is currently leaning towards the higher band of the 52-week range of USD 17.27 to USD 26.07. We have valued the stock using the Price/Cash Flow-based relative valuation methodology and arrived at a target price of USD 22.89.

Considering the company's longer cash cycle, industry below ROE, current valuation and associated risks. we recommend a "Sell" rating on the stock at the closing price of USD 25.44, up 0.16% as of April 12, 2022.

                          

Three-Year Technical Price Chart (April 12, 2022). Source: REFINITIV, Analysis by Kalkine Group

* The reference data in this report has been partly sourced from REFINITIV.

* All forecasted figures and industry information have been taken from REFINITIV.


Disclaimer

The advice given by Kalkine Canada Advisory Services Inc. and provided on this website is general information only and it does not take into account your investment objectives, financial situation and the particular needs of any particular person. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. The website www.kalkine.ca is published by Kalkine Canada Advisory Services Inc. The link to our Terms & Conditions has been provided please go through them. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.

Past performance is not a reliable indicator of future performance.